CD8A and neoplasm: Meanwhile, Stk24 deficiency in CT26 or MC38 tumor cells combined with the anti‐PD1 therapy strongly boosted the intratumoral infiltration (Figure S7A,B, Supporting Information) and activation of CD8+T or NK cells (Figure S7C,D, Supporting Information).